About NicOx

Profile
Pipeline
Corporate factsheet

Products
Naproxcinod
NCX 4016
NCX 6560
Full portfolio
Maximizing portfolio
Co-development
Research alliances
Technology
People
Board of Directors
Management Team
Contacts
Careers
Investor & media
Press releases
Investor relations

Fact file
Financials
Corporate governance

Scientific publications
Conferences
Home
Directions to NicOx
Site en français


Vaughn M. KAILIAN - General Partner, MPM Capital
Vaughn M. Kailian became Co-chairman of the Board of Directors of Millennium Pharmaceuticals, Inc. in February 2002, following Millennium's acquisition of COR Therapeutics, Inc. where he had served as CEO, President and Director since March 1990.

Mr. Kailian is a member of the Pharmaceutical Foundation Advisory Council at the University of Texas at Austin and the University of Florida.

He is a Director of Amylin Pharmaceuticals, Inc., the Biotechnology Industry Organization (BIO) and Chairman of the California Health Care Institute.

After graduating from Tufts University, Mr. Kailian was employed by Marion Merrell Dow, Inc., a pharmaceutical company, and its predecessor companies, in various international and U.S. management, marketing and sales positions from 1967 to 1990, including General Manager, Merrell Dow USA, and President and Corporate Vice President of Global Commercial Development, Marion Merrell Dow, Inc.